Kate Rochlin
President & COODr. Kate Rochlin, Ph.D., is the Chief Operating Officer of IN8bio, Inc since December 2021 and serves as its President since February 9, 2026. She was Vice President of Operations and Innovation since December 2020 until December 2021 and previously served as our Associate Vice President of Operations and Innovation from August 2020 until December 2020. Since joining IN8bio in August 2020, She has been a major contributor to operations. Since February 2013, Dr. Rochlin has served as a Project Principle of the Solution Lab, Inc., a nonprofit organization that provides Ph.D. and MBA students real-world consulting experiences and since October 2019 she has also served on the Solution Lab’s board of directors. From March 2020 until August 2020, Dr. Rochlin served as the Chief Business Officer of Curadigm SAS, a private nanotechnology company. Previously she served as Curadigm’s Director of Business Development from March 2019 to August 2020. Prior to that, Dr. Rochlin Served as Director of Scientific Affairs for Filament BioSolutions Inc., a private biotechnology company, from March 2016 until March 2019. From September 2012 to January 2017, she was a Co-founder and the Chief Scientific Officer of Immunovent, LLC, a biotechnology company focused on commercialization of technologies for diagnosing allergies and then served as a Scientific and Business Advisor to Immunovent, LLC from January 2017 until March 2019. Dr. Rochlin received a Ph.D. in Molecular Biology and Genetics from Weill Cornell Medical College and conducted research at the Memorial Sloan Kettering Cancer Center and a B.A. with double majors in Molecular Biology and History and Sociology of Science (HSSC) from the University of Pennsylvania.
公司职务
- 公司名称IN8bio, Inc.股票代码INAB职务President & COO共事同僚
- THTai-Wei HoCo-Founder, CEO & Director
- JRJeremy R. GraffInterim Independent Chair
- PMPatrick McCallCFO & Secretary
- LSLawrence S. LambExecutive VP, Co-Founder & Chief Scientific Officer
- OPOxana PolyakovaSenior Vice President of Research & Development
- PCPeter C. BrandtIndependent Director
- LGLuba GreenwoodIndependent Director
- EWEmily Wang FairbairnIndependent Director
